MOMTAZEE JAMES C bought ROIV
September 10, 2025 · Form 4 insider transaction
MOMTAZEE JAMES C bought 14,524 shares of Roivant Sciences Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,524
Price
$0.00
Total value
N/A
InsiderMOMTAZEE JAMES C
RoleDirector
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateSeptember 10, 2025
Filing dateSeptember 12, 2025
Shares owned after111,194
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date.